Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.
D000818:Animals; D004195:Disease Models, Animal; D005434:Flow Cytometry; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D000071447:N-Myc Proto-Oncogene Protein; D009447:Neuroblastoma / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D009687:Nuclear Proteins / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage / Q000494:pharmacology*; D015513:Oncogene Proteins / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology*; D014162:Transfection
C459801:MYCN protein, human; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D016376:Oligonucleotides, Antisense; D015513:Oncogene Proteins